LAB · Standard BioTools Inc.
AI read · Neutral
The AI's read
The vote clears a shareholder step, but the merger has not yet taken effect. The approved changes include issuing shares and selling the Element Mass Cytometry business. The filing gives no sale price or expected financial results, so it does not show whether these changes help or hurt LAB.